Log in

Relevant bibliographies by topics / Neurodegenerative / Books

Books on the topic 'Neurodegenerative'

To see the other types of publications on this topic, follow the link: Neurodegenerative.

Author: Grafiati

Published: 4 June 2021

Last updated: 21 February 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Neurodegenerative.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Neurodegenerative diseases. Austin, Tex: Landes Bioscience, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Dominguez, Celia, ed. Neurodegenerative Diseases. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-642-16758-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Galimberti, Daniela, and Elio Scarpini, eds. Neurodegenerative Diseases. London: Springer London, 2014. http://dx.doi.org/10.1007/978-1-4471-6380-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Hardiman, Orla, Colin P. Doherty, Marwa Elamin, and Peter Bede, eds. Neurodegenerative Disorders. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-23309-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Hardiman, Orla, and Colin P. Doherty, eds. Neurodegenerative Disorders. London: Springer London, 2011. http://dx.doi.org/10.1007/978-1-84996-011-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Galimberti, Daniela, and Elio Scarpini, eds. Neurodegenerative Diseases. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-72938-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Ahmad, Shamim I., ed. Neurodegenerative Diseases. New York, NY: Springer US, 2012. http://dx.doi.org/10.1007/978-1-4614-0653-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Beart, Philip, Michael Robinson, Marcus Rattray, and Nicholas J. Maragakis, eds. Neurodegenerative Diseases. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-57193-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Fiskum, Gary, ed. Neurodegenerative Diseases. Boston, MA: Springer US, 1996. http://dx.doi.org/10.1007/978-1-4899-0209-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Ahmad, Shamim I. Neurodegenerative Diseases. New York, NY: Springer US, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

B, Caine Donald, ed. Neurodegenerative diseases. Philadelphia: W.B. Saunders Co., 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

Peplow, Philip V., Bridget Martinez, and Thomas A. Gennarelli, eds. Neurodegenerative Diseases Biomarkers. New York, NY: Springer US, 2022. http://dx.doi.org/10.1007/978-1-0716-1712-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Mattson, Mark P. Pathogenesis of Neurodegenerative Disorders. New Jersey: Humana Press, 2001. http://dx.doi.org/10.1385/159259106x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Verkhratsky, Alexei, Margaret S. Ho, Robert Zorec, and Vladimir Parpura, eds. Neuroglia in Neurodegenerative Diseases. Singapore: Springer Singapore, 2019. http://dx.doi.org/10.1007/978-981-13-9913-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Rai, Mahendra, and Alka Yadav, eds. Nanobiotechnology in Neurodegenerative Diseases. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-30930-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Mohamed, Essa, ed. Handbook of Neurodegenerative Disorders. Singapore: Springer Nature Singapore, 2023. http://dx.doi.org/10.1007/978-981-19-3949-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

W, Langston J., and Young Anne B. 1947-, eds. Neurotoxins and neurodegenerative disease. New York, N.Y: New York Academy of Sciences, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

Saghir, Atif N. Free radicals in neurodegenerative disease. Birmingham: University of Birmingham, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

Metal ions and neurodegenerative disorders. Singapore: World Scientific, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

20

Astrid, Sigel, Sigel Helmut, and Sigel Roland K. O, eds. Neurodegenerative diseases and metal ions. Chichester, West Sussex, England: Wiley, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

21

P, Doherty Colin, and SpringerLink (Online service), eds. Neurodegenerative Disorders: A Clinical Guide. London: Springer-Verlag London Limited, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

22

C, Mobley William, Christen Yves, and SpringerLink (Online service), eds. Intracellular Traffic and Neurodegenerative Disorders. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

23

Vega, Irving E., and Timothy J. Collier, eds. Unraveling Neuroprotective and Neurodegenerative Signals in Neurodegeneration. Frontiers Media SA, 2016. http://dx.doi.org/10.3389/978-2-88919-956-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Neurodegenerative Diseases. Springer, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

25

Trojanowski, John Q., John Q. Trojanowski M. D, Christopher Clark M. D, and Christopher M. Clark. Neurodegenerative Dementias. McGraw-Hill Professional, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

26

Dominguez, Celia. Neurodegenerative Diseases. Springer, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

27

Neurodegenerative Disorders. Greenhaven Press, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

28

Engdahl, Sylvia. Neurodegenerative Disorders. Greenhaven Publishing LLC, 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

29

Dominguez, Celia. Neurodegenerative Diseases. Springer, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

30

G, Jolles, Stutzmann J. M, and Rhône-Poulenc Round Table Conference (8th : 1993 : Annecy, France), eds. Neurodegenerative diseases. London: Academic Press, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

31

Neurodegenerative Disorders. HG group, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

32

Cummings, Jeffrey L., and Jagan A. Pillai, eds. Neurodegenerative Diseases. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780190233563.001.0001.

Full text

Abstract:

With an increasingly aging population, neurodegenerative diseases-such as Alzheimer’s disease, Lewy body dementia, frontotemporal dementia, and Parkinson’s disease-are becoming more prevalent in the world. This is an area of rapidly growing high-impact research as these neurodegenerative diseases are a huge burden for individuals, families, and societies both in quality of life and in healthcare costs. Finding novel therapeutic targets for neurodegenerative diseases is the premier medical challenge for this century. Classically each of these diseases has been viewed as a distinct entity with well-delineated clinical and pathological features. Recent research findings have revealed multiple commonalities across them; proteomic, genetic, cellular, and network mechanisms across neurodegenerative diseases. This conceptual revolution in our understanding of these neurodegenerative diseases as sharing unifying features is underpinned by underlying protein misfolding dysfunction and its consequences over time. As we search for new therapies and management of these neurodegenerative diseases, this book provides an effective source book of insights from experts that have played key roles in this conceptual revolution. Our goal is to enable better care of patients and to help build collaboration across research in multiple specializations that could help advance future insights and facilitate novel therapeutics.

APA, Harvard, Vancouver, ISO, and other styles

33

Cummings, Jeffrey L., and Jagan A. Pillai. Neurodegenerative Diseases. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780190233563.003.0001.

Full text

Abstract:

Neurodegenerative diseases (NDDs) are growing in frequency and represent a major threat to public health. Advances in scientific progress have made it clear that NDDs share many underlying processes, including shared intracellular mechanisms such as protein misfolding and aggregation, cell-to-cell prion-like spread, growth factor signaling abnormalities, RNA and DNA disturbances, glial cell changes, and neuronal loss. Transmitter deficits are shared across many types of disorders. Means of studying NDDs with human iPS cells and transgenic models are similar. The progression of NDDs through asymptomatic, prodromal, and manifest stages is shared across disorders. Clinical features of NDDs, including cognitive impairment, disease progression, age-related effects, terminal stages, neuropsychiatric manifestations, and functional disorders and disability, have many common elements. Clinical trials, biomarkers, brain imaging, and regulatory aspects of NDD can share information across NDDs. Disease-modifying and transmitter-based therapeutic interventions, clinical trials, and regulatory approaches to treatments for NDDs are also similar.

APA, Harvard, Vancouver, ISO, and other styles

34

Kishore, Uday, ed. Neurodegenerative Diseases. InTech, 2013. http://dx.doi.org/10.5772/45957.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Domínguez, Celia. Neurodegenerative Diseases. Springer Berlin / Heidelberg, 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

36

Ovádi, Judit, and Ferenc Orosz. Protein folding and misfolding : neurodegenerative diseases: Neurodegenerative diseases. Judit Ovadi, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

37

Zetterberg, Henrik, and Jonathan M. Schott. Fluid Biomarkers Indicative of Neurodegenerative Diseases. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780190233563.003.0008.

Full text

Abstract:

A major unifying feature of neurodegenerative diseases (NDDs) is excessive neuronal loss. Depending on when and where this occurs, patients may express distinct neurological and psychiatric symptoms. Neurodegeneration is accompanied by protein aggregation, inflammation, and microglial activation that may be drivers of the disease or in some circumstances may be protective reactions to the neurodegenerative process. A key development over the past decade has been our ability to leverage these accompanying central nervous system changes to develop clinically impactful biomarkers of specific NDDs. This has been crucial in helping us develop an understanding the time line of progression of these diseases, in their early diagnosis and to help target patients appropriately in therapeutic clinical trials, This chapter gives an overview of both established and novel fluid biomarkers for neurodegeneration, protein accumulation, inflammation, and microglial activation across different neurodegenerative diseases. Common as well as disease-specific biomarker changes in cerebrospinal fluid and blood are emphasized.

APA, Harvard, Vancouver, ISO, and other styles

38

Knott, Andrew B., and Ella Bossy-Wetzel. Mitochondrial Changes and Bioenergetics in Neurodegenerative Diseases. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780190233563.003.0012.

Full text

Abstract:

Mitochondria are dynamic organelles that are of critical importance for cellular survival and health. Because mitochondria play central roles in energy production and synaptic maintenance, neurons are believed to be particularly vulnerable to mitochondrial dysfunction. The discovery that genetic mutations in genes coding for mitochondrial proteins cause neurodegenerative conditions further hinted at the likelihood that mitochondrial dysfunction is a key pathway of neurodegeneration. Indeed, a wealth of research has identified mitochondrial dysfunction as an early and shared event of all common neurodegenerative diseases, both genetic and sporadic in origin. Specific types of mitochondrial dysfunction that have been observed in most neurodegenerative diseases include bioenergetic failure, increased oxidative stress, mitochondrial DNA mutations, defective calcium handling, impaired mitochondrial dynamics, defective mitophagy, and decreased mitochondrial biogenesis. The search for drugs that successfully target these pathways of mitochondrial dysfunction in neurodegeneration is ongoing.

APA, Harvard, Vancouver, ISO, and other styles

39

1952-, Marwah J., and Teitelbaum Herman, eds. Advances in neurodegenerative disorders. Scottsdale, Ariz: Prominent Press, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

40

Imaging of Neurodegenerative Disorders. Thieme Medical Publishers, Incorporated, 2015.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

41

Neurodegenerative Diseases: Unifying Principles. Oxford University Press, Incorporated, 2016.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

42

Imaging in Neurodegenerative Disorders. Oxford University Press, 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

43

Verkhratsky, Alexei, Vladimir Parpura, Margaret S. Ho, and Robert Zorec. Neuroglia in Neurodegenerative Diseases. Springer Singapore Pte. Limited, 2020.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

44

AMERICAN, SCIENTIFIC. Fragile Brain: Neurodegenerative Diseases. Blackstone Publishing, 2021.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

45

Editors, Scientific American. Fragile Brain: Neurodegenerative Diseases. Rosen Publishing Group, 2022.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

46

Mattson, Mark P. Pathogenesis of Neurodegenerative Disorders. Humana Press, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

47

Books, Gregg. Prions and Neurodegenerative Disease. Independently Published, 2020.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

48

Prasad, Kedar N. Neurodegenerative Disease and Micronutrients. CRC Press, 2014. http://dx.doi.org/10.1201/b17497.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

McBurney, John W. Pesticides and Neurodegenerative Disorders. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190490911.003.0008.

Full text

Abstract:

Neurodegenerative diseases, which are characterized by neuronal degeneration, include Alzheimer disease (AD), Parkinson disease (PD), and amyotrophic lateral sclerosis (ALS). Their worldwide prevalence is increasing as the global population ages. The causes reflect interactions between genetics and environmental factors such as increasing urbanization, industrialization, and widespread use of chemicals, including insecticides, fungicides, and herbicides. Epidemiologic data suggest that exposure to many of these pesticides increases the risk of neurodegeneration. The best-defined mechanism for this association is mitochondrial toxicity resulting in increased reactive oxygen species. In PD and AD, the associated accumulation of aggregates of insoluble, misfolded proteins results in the formation of Lewy bodies and neurofibrillary tangles, respectively. Pesticide exposures can be reduced by modifying food choices and applying integrated pest management in schools, businesses, and homes. Medical professionals can counsel patients about limiting exposure to pesticides and decreasing the risk of neurodegenerative disorders.

APA, Harvard, Vancouver, ISO, and other styles

50

Desikan, Rahul, Celeste Karch, and Leo P. Sugrue, eds. Genetics of Neurodegenerative Diseases. Frontiers Media SA, 2021. http://dx.doi.org/10.3389/978-2-88971-780-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!